WHAT'S NEXT IN AI-ENABLED,
PRECISION CARDIAC CARE

American College of Cardiology (ACC) – 74th Annual Scientific Session & Expo

BOOTH 16033

 

Experience Cleerly at ACC.25

Cleerly invites you to the ACC’s annual gathering of international experts sharing the latest in cardiac clinical research and innovation. This year, Cleerly is proud to officially partner with ACC in honor of their 75th Anniversary to support efforts to improve health equity within the community and the cardiovascular (“CV”) care delivery system. 

Stop by  Booth 16033 for live demos of Cleerly's technology, clinical evidence, and expert discussions with our leadership team throughout the conference. We’ll showcase Cleerly’s personalized coronary CT analysis, designed to streamline workflows, enhance diagnostic accuracy and empower healthcare professionals to make confident, data-driven decisions for better patient outcomes.

Don’t miss your chance to experience the future of cardiac care firsthand.

ACC 74th Annual
Scientific Sessions & Expo

 

 

Visit us at:

BOOTH 16033

 

Book a private meeting with Cleerly

 

Schedule Now

AHA-2023-meet-greet-food

Meet Cleerly Leadership and Partners

 

Join us for an exclusive small-group session with Cleerly’s executive and clinical leadership. A lunch-style buffet and coffee bar with barista service will be provided!

Booth 16033
March 30, 12:30 PM - 1:30 PM

Jim Min, MD, Founder and CEO, Cleerly

James K. Min, MD
Founder and CEO, Cleerly

James Earls, MD, Chief Medical Officer, Cleerly

James Earls, MD
Chief Medical Officer, Cleerly

Udo Hoffmann, MD, Chief Scientific Officer, Cleerly

Udo Hoffmann, MD
Chief Scientific Officer, Cleerly

Jim Hartman, Chief Revenue Officer, Cleerly

Jim Hartman
Chief Revenue Officer, Cleerly

 

Join Cleerly at ACC.25 Events

Demonstrations daily // Saturday through Monday at Booth 16033

Saturday, March 29th
9:00 AM - 4:45 PM

Exhibit Hall Hours // Cleerly Booth 16033

9:30 - 10:30 AM
Sophie Cramer
South Hall

A Novel Definition Of Percent Diameter Stenosis: Diagnostic Performance Data From Credence And Pacific-1

Session: 1022 - Featured Fields 01

3:30 - 4:30 PM
Sarah Bär
South Hall

Benefit of Revascularization vs. Medical Therapy According to Artificial Intelligence- Guided Plaque Burden from Coronary Computed Tomography Angiography

Session 1107 - Multimodal Imaging 05

3:30 - 4:30 PM
Putri Annisa Kamila
South Hall

Diagnostic Performance of AI-QCT ISCHEMIA for Abnormal FFR Across Various Plaque Types and Burdens

Session 1107 - Multimodal Imaging 05

Sunday, March 30th
9:00 AM - 4:45 PM

Exhibit Hall Hours // Cleerly Booth 16033

10:30 - 11:30 AM
Teemu Maaniitty
South Hall

Quantification Of Coronary Atherosclerotic Plaque Burden To Determine Who Benefit From Lipid-Lowering Medication: A 7- Year Outcomes Study

Session 1147 - Multimodal Imaging 07

12:30 - 1:30 PM
Booth 16033

Meet Cleerly Leadership and Partners

Join us for an exclusive small-group session with Cleerly’s executive and clinical leadership. A lunch-style buffet and coffee bar with barista service will be provided!

1:00 - 1:30 PM
Michelle Gearhart, PharmD
Education Zone, Theater 1 of the Lounge and Learn Pavilion

Increasing Female Physician Leadership in Clinical Trials

Session 5040 - ACC.25 Lounge & Learn Session

2:00 - 4:00 PM

Specific Contribution:
3:00 - 3:07 PM

Juan Lopez-Mattei, MD
Moderated Poster Theater 3

Cost Effectiveness of Coronary Plaque Analysis in a prevention Program

Main Session: 977 - Costs of Cardiovascular Preventive Care: Implications Across Stakeholders

Specific Contribution: 977-13

2:30 - 3:30 PM
James Min, MD
Health Equity Hub, Expo #17047

A Cross-Industry Panel Discussion on Community Education, Cardiovascular Disease Prevention, and Screening Programs

Session 4705 - Championing Communities of Health

Monday, March 31st
9:00 AM - 2:00 PM

Exhibit Hall Hours // Cleerly Booth 16033

9:00 - 10:00 AM

Specific Contribution:
9:12 - 9:20 AM

Gudrun Feuchtner, MD
S100B

Artificial intelligence-based quantitative computed tomography (AI-QCT) coronary plaque features predict risk more pronounced in females: The international multicentric registry CONFIRM2 (COroNary CT Angiography Evaluation For Evaluation of Clinical Outcomes)

Main Session: 402 - Clinical and Investigative Horizons I

Specific Contribution: 402-10

11:30 AM - 1:30 PM

Specific Contribution:
11:54 AM - 12:01 PM

Putri Annisa Kamila
Moderated Poster Theater 8

Refining Myocardial Ischemia Diagnosis: Rule-In and Rule-Out Approach Using Quantitative Coronary CT Assessment.

Main Session: 1012 - Cardiac CT as a Prognostic Tool: Ready for Implementation?

Specific Contribution: 1012-07

ACC 74th Annual Scientific Sessions & Expo

 

 

Visit us at:

BOOTH 16033

 

 

Book a private meeting with Cleerly

 

Schedule Now
Patents

Cleerly continues to revolutionize heart attack and cardiovascular disease prevention and treatment everyday by inventing world-class technology. Cleerly invests significant time and resources in research and development towards this goal. To protect Cleerly’s research and development efforts, Cleerly has vigorously developed a robust intellectual property portfolio – all part of a strategy for protecting the innovations that make Cleerly an industry leader in cardiovascular disease prevention and treatment.

Cleerly’s products and services may be covered by or for use under one or more of U.S. Patent Nos. 12,245,882, 12,144,669, 11,922,627, 11,948,301, 11,861,833, 11,967,078, 12,141,976, 11,210,786, 11,232,564, 11,276,170, 11,288,799, 11,302,001, 11,315,247, 11,367,190, 11,690,586, 11,751,826, 11,779,292, 11,832,982, 11,969,280, 12,193,862, 11,094,061, 11,094,060, 11,113,811, 11,120,550, 11,120,549, 11,132,796, 11,238,587, 11,244,451, 11,302,002, 11,308,617, 11,321,840, 11,341,644, 11,501,436, 11,660,058, 11,672,497, 11,730,437, 11,737,718, 11,751,830, 11,751,829, 11,766,230, 11,766,229, 11,896,415, 12,023,190, 12,076,175, 12,097,063, 12,156,759, 12,171,606, 12,178,627, 10,813,612, 11,317,883, 11,350,899, 11,642,092, 11,751,831, 11,759,161, and 12,138,093, as well as other patents that are pending.

For additional information, please contact legal@cleerlyhealth.com.

Solutions
About

© 2025 Cleerly, Inc.